Misonix and Mentor prolong ultrasound agreement
This article was originally published in Clinica
Minimally-invasive ultrasound specialist Misonix and Mentor, a firm focused on developing medical devices for the aesthetics market, have extended a distribution agreement for the former’s Lysonix 3000 ultrasound-assisted liposuction system. The deal, which prolongs a previous agreement struck in September 2007 by one year, sees Mentor retain exclusive distribution rights to the Lysonix system in the US and gain non-exclusive rights to the technology for certain unspecified foreign markets. According to Farmingdale, New York-based Misonix, the agreement includes minimum purchase requirements which represent “significant growth over the previous year”. Exact financial terms of the extension were not disclosed.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals